Kane Logo Cropped TransBG.png
Kane Biotech Announces Private Placement Offering
March 15, 2022 07:00 ET | Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, March 15, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
Kane Logo Cropped TransBG.png
Kane Biotech Announces New Collaboration Agreements for Prosthetic Joint Infection, expanding its DispersinB® applications
February 10, 2022 08:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has signed collaboration agreements with Dr. James Doub, MD, Assistant Professor of Medicine, University of...
Kane Logo Cropped TransBG.png
Wound Care Commercialization to be a Key Company Focus in 2022
January 20, 2022 12:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Kane Biotech CEO, Marc Edwards sees its rich 20-year history of biofilm research and product development as a real strategic advantage in the...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Third Quarter 2021 Financial Results
November 16, 2021 16:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today announced their third quarter 2021 financial results. ...
Kane Logo Cropped TransBG.png
Kane Biotech to Release Third Quarter 2021 Financial Results on November 16 – Conference Call to Follow
November 09, 2021 08:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Announces New Credit Facility
September 02, 2021 08:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has entered into an amended and restated...
Kane Logo Cropped TransBG.png
STEM Animal Health completes first shipment of bluestem™ oral care products to PetSmart® Canada
August 31, 2021 08:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that STEM Animal Health Inc., has shipped its first order of bluestem™ products to PetSmart® Canada, Canada largest...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Second Quarter 2021 Financial Results
August 26, 2021 16:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its Second Quarter 2021 financial results. Second...
Kane Logo Cropped TransBG.png
Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 – Conference Call to Follow
August 19, 2021 16:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+™ Technology for Wound Care, Skin Infections and Personal Care Formulations
July 29, 2021 08:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, July 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has received two Decisions to Grant from the European Patent Office for patents covering its best-in-class...